3 Different Test Types. Better Results.

Biochemical Genetic Testing

Biochemical Genetic Testing

Molecular Genetic Testing

Molecular Genetic Testing

Cytogenetic Testing

Cytogenetic Testing

Medical EmExome: Clinical Exome Sequencing

Improved turnaround times and reduced pricing

Improved turnaround times and reduced pricing

3 years of clinical experience have optimized the process, making clinical exome sequencing more cost-effective and less time-consuming.

Enhanced coverage of disease-associated genes

Enhanced coverage of disease-associated genes

Enhanced coverage of ~4600 medically relevant and known disease-associated genes. With EmExome Boost, choose a panel relevant to the patient's phenotype to ensure complete coverage of all exons on the gene panel.

Flexible testing options

Flexible testing options

6 testing options: Medical EmExome (Family Trios); Medical EmExome (Proband Only); Medical EmExome (Additional Family Member); Medical EmExome Array: Deletion/Duplication Analysis; Sanger Confirmation and Interpretation; and Interpretation Only.

In The Spotlight

Alice Tanner

Dr. Tanner is a board-certified molecular geneticist and a laboratory director for the Molecular Genetics Laboratory.

New and Updated Gene Panels

Industry-leading number of gene panels

EGL Next Generation Sequencing Panels include comprehensive, evidence-based gene lists, improved turnaround times, and reduced pricing.

Thyroid cancer can occur at any age, but about two-thirds of all cases are found in people between the ages of 20 and 55. Inherited thyroid cancer syndromes include multiple endocrine neoplasia MEN type 2A, MEN type 2B, and familial medullary thyroid cancer (FMTC).

EGL Clients From Around the World

Emory Genetics Laboratory is pleased to have clients from all over the globe. Interested in sending us testing? Please contact egl.marketing@emory.edu.